Ledger.Open graph →
SEC Form D · Amendment · filed March 6, 2026

GelSana Therapeutics, Inc

Offering
$3.7M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AURORA, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Dan Fipke · Houston, TXDirectorJake Bainbridge · Houston, TXExec · DirectorJohn V. Harris · Cleveland, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗